In order to overcome the difficulties of TAA-pulsed DC as vaccine, we returned in this study to the pre-clinical situation using a poor immunogenic AFP-expressing HCC model using mAFP stably transfected murine hepatoma Hepa129-cells. The gene discussed is AFP; the disease is hepatocellular carcinoma.